Variables | SPK (n = 101) | KTA (n = 26) | P-value |
---|---|---|---|
Donor | |||
Age, years | 24.2 ± 11.9 | 59.7 ± 17.4 | < 0.001 |
Gender | |||
Male | 60 (69.4%) | 12 (46.2%) | 0.224 |
Female | 41 (40.6%) | 14 (53.8%) | |
BMI, kg/m2 | 22.4 ± 3.1 | 25.4 ± 3.5 | < 0.001 |
Recipient | |||
Age, years | 42.9 ± 8.8 | 61.5 ± 8.6 | < 0.001 |
Gender | |||
Male | 57 (56.4%) | 21 (80.8%) | 0.023 |
Female | 44 (43.6%) | 5 (19.2%) | |
BMI, kg/m2 | 25.1 ± 4.2 | 28.6 ± 3.1 | < 0.001 |
Smokers, n | 21 (21%) | 7 (27%) | 0.501 |
Duration of IDDM, years | 26.6 ± 8.5 | 18.9 ± 8.9 | < 0.001 |
Duration of dialysis, years | 2.7 ± 2.6 | 7.4 ± 4.1 | < 0.001 |
Hypertension | |||
Yes | 87 (86.1%) | 23 (88.5%) | 0.756 |
No | 14 (13.9%) | 3 (11.5%) | |
Blood pressure, mmHg | |||
Systolic | 135 ± 17 | 141 ± 18 | 0.03 |
Diastolic | 76 ± 10 | 82 ± 11 | 0.02 |
Antihypertensive drugs, n | 2.6 ± 1.3 | 2.0 ± 1.5 | 0.046 |
Arterial obstructive disease | |||
Yes | 17 (16.8%) | 8 (30%) | 0.114 |
No | 84 (83.2%) | 18 (70%) | |
Coronary heart disease | |||
Yes | 29 (28.7%) | 19 (73.1%) | < 0.001 |
No | 71 (71.3%) | 7 (26.9%) | |
Time on waiting list, months | 10.4 ± 13.1 | 22.3 ± 28.4 | 0.012 |
Pre-emptive transplant | 22 (24.7%) | 2 (7.7%) | 0.032 |
Immunosuppression | |||
Induction therapy | |||
ALG/ATG | 74 (73.3%) | 4 (15.4%) | 0.001 |
IL2-RA | 19 (18.8%) | 12 (46.2%) | |
None | 8 (7.9%) | 10 (38.5%) | |
CNI | |||
Tacrolimus | 97 (96.0%) | 25 (96.2%) | 0.979 |
Cyclosporin | 4 (4%) | 1 (4.5%) | |
AP drug | |||
MMF | 83 (82.2%) | 22 (84.6%) | 0.002 |
SRL | 14 (13.9%) | 0 | |
Multiple | 3 (3.0%) | 0 | |
None | 1 (1%) | 4 (15.4%) |